MedDRA system organ classes1 | Identified PRO-CTCAE symptoms based on two core outcome sets2,3 | Identified symptoms from product summaries and phase III clinical studies4,5,6, aligned with matching PRO-CTCAE symptoms7 | Final PRO-CTCAE symptoms7 included in the PRO tool |
---|---|---|---|
Gastrointestinal disorders | |||
 | Constipation | Constipation | Constipation |
 | Diarrhea | Diarrhea | Diarrhea |
 | Nausea | Nausea | Nausea |
 | Bloating | Mouth/throat sores | Mouth/throat sores |
 | Vomiting | Vomiting | Vomiting |
 |  |  | Bloating |
General disorders and administration site conditions | |||
 | Fatigue | Fatigue | Fatigue |
 | Abdominal pain | General pain | Abdominal pain |
Metabolism and nutrition disorders | |||
 | Decreased appetite | Decreased appetite | Decreased appetite |
Musculoskeletal and connective tissue disorders | |||
 |  | Joint pain | Joint pain |
 |  | Muscle pain | Muscle pain |
Nervous system disorders | |||
 | Numbness & tingling | Numbness & tingling | Numbness & tingling |
Psychiatric disorders | |||
 | Anxious |  | Anxious |
 | Concentration |  | Concentration |
 | Discouraged |  | Discouraged |
 | Memory |  | Insomnia |
 | Insomnia |  | Memory |
 | Sad |  | Sad |
Reproductive system and breast disorders | |||
 | Sexual dysfunction |  | Decreased libido |
 | Vaginal dryness |  | Vaginal dryness |
Respiratory, thoracic and mediastinal disorders | |||
 | Shortness of breath | Shortness of breath | Shortness of breath |
Skin and subcutaneous tissue disorders | |||
 |  | Hair loss |  |
 |  | Nail loss |  |
 |  | Nail ridging |  |
 |  | Nail discoloration |  |
 |  | Rash |  |
Investigations | |||
 |  | Taste changes |  |
Unique symptoms, total | 18 | 18 | 21 |